Dana Pizzuti - 30 Sep 2022 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role: Chief Development Officer
Signature: /s/ Marc Wilson, as attorney-in-fact
Issuer symbol: CRNX
Transactions as of: 30 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 11 Oct 2022, 16:30:37 UTC
Next filing: 11 Oct 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power-of-Attorney